Ishares Tr genomics immun shares owned by Citigroup
Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Ishares Tr genomics immun
Tip: Access up to 7 years of quarterly data
All positions including Ishares Tr genomics immun held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ishares Tr genomics immun by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.2k | 400 | 23.01 |
| 2023-09-30 | $8.1k | 400 | 20.35 |
| 2023-03-31 | $9.3k | 400 | 23.27 |
| 2022-12-31 | $10k | 400 | 25.17 |
| 2022-09-30 | $11k | 400 | 27.50 |
| 2021-12-31 | $18k | 400 | 45.00 |
| 2021-03-31 | $18k | 400 | 45.00 |